Physician Rewards for Postmarketing Surveillance (Seeding Studies) in the US John La Puma Guest Editorial 17 November 2012 Pages: 187 - 190
Minimising the Cost of Urinary Incontinence in Nursing Homes Judy SteelDavid Fonda Leading Article 17 November 2012 Pages: 191 - 197
Economic Decision Making in Healthcare Alan L. HillmanMyoung S. Kim Leading Article 17 November 2012 Pages: 198 - 205
Relationships Between Sponsors and Investigators in Pharmacoeconomic and Clinical Research Kevin A. SchulmanL. Elizabeth RubensteinJohn M. Eisenberg Review Article 17 November 2012 Pages: 206 - 220
Defining the Patient Group for Cost-Effective Withdrawal of Antihypertensive Therapy Lawrence R. KrakoffSylvia Wassertheil-Smoller Review Article 17 November 2012 Pages: 221 - 228
Quality-of-Life Instruments for Severe Chronic Mental Illness Marion Becker Review Article 17 November 2012 Pages: 229 - 237
Effect of Lenograstim on the Cost of Autologous Bone Marrow Transplantation Pauline BriceSylvie GodinChristian Gisselbrecht Original Research Article 17 November 2012 Pages: 238 - 241
The Cost Effectiveness of Hypertension Treatment in Sweden Magnus Johannesson Original Research Article 17 November 2012 Pages: 242 - 250
Pharmacoeconomic Analysis of Topical Treatments for Tinea Infections Neil H. ShearThomas R. EinarsonJohn J. Doyle Original Research Article 17 November 2012 Pages: 251 - 267
Alglucerase: The Debate Continues Stephen PushAlan M. Garber Correspondence 17 November 2012 Pages: 268 - 269